Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Cardiovascular Disorders » Percutaneous Valve Technology: Present and Future Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
$160.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Rheumatic Mitral Valve Disease: Percutaneous Balloon Mitral Valvuloplasty, Present and Future Perspectives (pp. 523-564)
Tell A Friend
 
Tell someone you know about this product.
Rheumatic Mitral Valve Disease: Percutaneous Balloon Mitral Valvuloplasty, Present and Future Perspectives (pp. 523-564) $100.00
Authors:  (Bernard Iung and Alec Vahanian)
Abstract:
Since it description in 1984, percutaneous mitral commissurotomy (PMC) has been widely used and its indications have been progressively widened. The Inoue technique is now the most widely used, in particular because of its ease of use and its safety, as attested by the low rates of mortality and complications seen in series from experienced centers. The most frequent complication is severe traumatic mitral regurgitation. Immediately after PMC, there is a mean doubling of mitral valve area. Good late functional results are observed in 33 to 72% of patients at 10-12 years, the wide range of rates depending on differences in patient characteristics between series. The most frequent cause of late deterioration is mitral restenosis. Analyses performed in large series have shown that the prediction of immediate and late results of PMC is multifactorial. Besides the severity of the impairment of valve anatomy, age, symptoms, atrial fibrillation and prior commissurotomy have a strong impact on patient outcome.
According to guidelines, percutaneous mitral commissurotomy is now the reference treatment for mitral stenosis with pliable valves in young patients and its efficacy has been validated in randomised trials versus surgery. Mitral stenosis in older patients with more severe impairment of valve anatomy is the most frequent presentation of mitral stenosis in industrialized countries. In this heterogeneous group, PMC should be considered in patients who have otherwise favourable characteristics. PMC can also be considered in selected asymptomatic patients, in particular in order to reduce the thromboembolic risk.
After more than 20 years, PMC is now a mature technique and has virtually replaced surgical commissurotomy in industrialised countries. PMC and valve replacement should be considered as complementary techniques applicable in the different stages and presentations of mitral stenosis. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.The New Science of Curiosity
03.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
04.Chronic Disease and Disability: The Pediatric Lung
05.Fruit and Vegetable Consumption and Health: New Research
06.Future Perspectives on Nigella sativa: Characterization and Pharmacological Properties
07.Wine and Winemaking: The Value and Efficiency
08.Impacts and Challenges in Oil Palm Cultivation and Downstream Applications of Biomass
09.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2
10.The Life and Times of the World's Most Famous Mathematicians
11.Innovation Processes in the Social Space of the Organization
12.High-Strength Steels: New Trends in Production and Applications

Nova Science Publishers
© Copyright 2004 - 2018

Rheumatic Mitral Valve Disease: Percutaneous Balloon Mitral Valvuloplasty, Present and Future Perspectives (pp. 523-564)